We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA is considering tightening up its requirements for OTC topical antiseptic products with a proposal that calls for a slew of new effectiveness and safety data. Read More
Public Citizen is calling on the FDA to add a boxed warning to a class of drugs for treating Parkinson’s disease and ADHD to address a potential link to behavioral problems. Read More
The FDA has released draft guidance on conflict of interest for advisory board participants, detailing the agency’s process for determining whether a committee member’s connections create the appearance of bias. Read More
Industry is asking the FDA to clarify key elements of its updated draft guidance on assessing the effects of protein-based treatments on the immune system. Read More